menu
    • menu

    Company profile for Clearmind Medicine

    NEW Drugs in Dev: 4
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Clearmind Medicine (CSE: CMND) develops novel psychedelic medicines to solve widespread, yet under-served, health problems. With a strong medical management team and IP-protection, we can better the lives of millions. With a clear focus on alcohol abuse and binge drinking, Clearmind's first drug candidate addresses very common (and costly) afflictions which to date, have limited solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clearmind MedicineCanada Flag
    Country
    Country
    Canada
    Address
    Address
    101 – 1220 W 6 Ave Vancouver, BC V6H1A5
    Telephone
    Telephone
    (778) 400 5347
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.clearmindmedicine.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clearmind-medicine/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PCHi

    PCHi

    Not Confirmed

    envelop Contact Supplier

    PCHi

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scisparc, Clearmind Medicine Partner For Depression Therapy
    Scisparc, Clearmind Medicine Partner For Depression Therapy

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256253/0/en/SciSparc-NeuroThera-Labs-Clearmind-Medicine-Collaboration-Leads-to-Patent-Application-for-Depression-Therapy.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Clearmind Medicine Files Hong Kong Patent For Depression Therapy
    Clearmind Medicine Files Hong Kong Patent For Depression Therapy

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255403/0/en/Clearmind-Medicine-Announces-Hong-Kong-Patent-Filing-for-Depression-Therapy.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    NeuroThera Labs, Clearmind Announce Weight Loss Patent
    NeuroThera Labs, Clearmind Announce Weight Loss Patent

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254524/0/en/SciSparc-NeuroThera-Labs-Announces-Publication-of-International-Patent-in-Collaboration-with-Clearmind-Medicine-for-Novel-Therapy-Targeting-Weight-Loss-and-Fatty-Liver-Disease.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Clearmind Medicine Advances to CMND-100 Trial's Third Cohort
    Clearmind Medicine Advances to CMND-100 Trial's Third Cohort

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253850/0/en/Clearmind-Medicine-Advances-Recruitment-for-CMND-100-Trial-s-Third-Cohort-at-Yale-Johns-Hopkins-and-Tel-Aviv-Sites-Following-Recent-Positive-Topline-Results.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    Clearmind Advances to Next Trial Phase on DSMB Nod
    Clearmind Advances to Next Trial Phase on DSMB Nod

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249262/0/en/Clearmind-Medicine-Moving-Forward-to-the-Next-Stage-of-Its-Clinical-Trial-Following-Data-and-Safety-Monitoring-Board-Approval.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Clearmind Medicine Reports Positive Safety Data For CMND-100
    Clearmind Medicine Reports Positive Safety Data For CMND-100

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234516/0/en/Clearmind-Medicine-Announces-Additional-Topline-Positive-Safety-Results-Reinforcing-Favorable-Profile-of-CMND-100-in-Ongoing-Phase-I-IIa-Clinical-Trial.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search